Details of the Drug Combinations

General Information of This Drug (ID: DMUTSRW)

Drug Name

Dexpanthenol DMUTSRW

Synonyms

d-Pantothenol; (2S)-2,4-dihydroxy-N-(3-hydroxypropyl)-3,3-dimethylbutanamide; L-Pantothenol; CAS-81-13-0; ( )-Panthenol; AC1NX8S7; KSC490G8B; SCHEMBL807508; CHEMBL1741351; CTK3J0380; SNPLKNRPJHDVJA-SSDOTTSWSA-N; ZINC1567243; ANW-37417; AKOS024438122; RTX-012330; NCGC00016326-01; AJ-27156; CJ-05387; UNII-WV9CM0O67Z component SNPLKNRPJHDVJA-SSDOTTSWSA-N

Indication

Disease Entry	ICD 11	Status	REF
Amenorrhea	GA20.0	Approved	[1]
Gastroparesis	DA41.00	Approved	[1]
Skin disease	EA00-EM0Z	Approved	[1]
Wound healing	EL8Y	Approved	[2]
------------------------------------------------------------------------------------

Drug Type

Small molecular drug

Structure

3D MOL

2D MOL

List of Combinatorial Drugs (CBD) Containing This Drug

1 Clinical Trial Drug Combination(s) Consisting of This drug

DrugCom Name	DrugCom ID	Component Drug	Indication	REF
Capecitabine + Dexpanthenol	DCGNOCH	Capecitabine	Breast Cancer	[3]
------------------------------------------------------------------------------------

References

1	Riboflavin FDA Label
2	Drugs@FDA. U.S. Food and Drug Administration. U.S. Department of Health & Human Services. 2015
3	ClinicalTrials.gov (NCT00661102) A Study of Prophylactic Treatment for Hand-Foot Syndrome in Patients Treated With Oral Xeloda (Capecitabine).